Jackson Square Partners’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-236,707
Closed -$77.1M – 85
2024
Q1
$77.1M Sell
236,707
-45,441
-16% -$11.2M 3.21% 7
2023
Q4
$53.8M Buy
+282,148
New +$53.3M 1.75% 26

Other funds holding SWAV

Jackson Square Partners's SWAV Position: Q2 2024 in Review

Jackson Square Partners sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 236,707 shares — an estimated $77.1M sold.

Jackson Square Partners first reported a position in SWAV in Q4 2023 and held it in 2 quarters. The position peaked at $77.1M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Jackson Square Partners reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Jackson Square Partners sold 236,707 Shockwave Medical shares in Q2 2024, an estimated $77.1M.
  • Jackson Square Partners first reported a position in Shockwave Medical in Q4 2023 and held it in 2 quarters.
  • Jackson Square Partners's Shockwave Medical position peaked at $77.1M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Jackson Square Partners's 13F filing for Q2 2024, filed 13 Aug 2024.